RNAZ
NASDAQ · Biotechnology
Transcode Therapeutics Inc
$6.60
-0.19 (-2.78%)
Open$6.99
Previous Close$6.79
Day High$7.22
Day Low$6.56
52W High$20.99
52W Low$6.08
Volume—
Avg Volume9.3K
Market Cap6.22M
P/E Ratio—
EPS$-95.84
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+200.3% upside
Current
$6.60
$6.60
Target
$19.82
$19.82
$14.35
$19.82 avg
$27.60
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.00M | 1.95M | 1.64M |
| Net Income | -582,985 | -504,236 | -420,334 |
| Profit Margin | -29.1% | -25.9% | -25.6% |
| EBITDA | -690,102 | -649,673 | -530,744 |
| Free Cash Flow | -724,048 | -502,155 | -609,665 |
| Rev Growth | -0.1% | -1.2% | +14.7% |
| Debt/Equity | 1.05 | 0.94 | 0.99 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |